Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case–control study based on the China Health and Retirement Longitudinal Study (CHARLS)

OBJECTIVES: Synergism between the metabolic syndrome (MetSyn) components and cancer incidence still remains inconclusive. We aimed to investigate the unique or joint role of MetSyn components in cancer onset. DESIGN: We conducted a prospective nested case–control study based on the China Health and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Meng, Fang, Xu, Dongkui, Xu, Lingkai, Qiu, Junlan, Shu, Xiaochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486362/
https://www.ncbi.nlm.nih.gov/pubmed/36115664
http://dx.doi.org/10.1136/bmjopen-2022-061362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486362/
https://www.ncbi.nlm.nih.gov/pubmed/36115664
http://dx.doi.org/10.1136/bmjopen-2022-061362

Ejemplares similares